📌 Key Takeaways
- Topic: How to Choose a Silica Manufacturer: Capacity, Quality Control and Certifications
- Keywords: monodisperse silica spheres
- Published: 2026-11-20 04:25:47
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica COA: What a Certificate of Analysis Should Include and How to Verify It
- What Is the Refractive Index of Silica? Values for Fused Silica, Quartz and Amorphous Silica
- Calcium Carbonate Filler vs Silica: Performance, Cost and Applications Compared
- What Is Spherical Silica? Benefits, Specifications and Uses in Semiconductor Packaging
- Malekmohammadi, S., Hadadzadeh, H., Rezakhani, S. & Amirghofran, Z. Design and synthesis of gatekeeper coated dendritic silica/titania mesoporous nanoparticles with sustained and controlled drug release properties for targeted synergetic chemo-sonodynamic therapy. ACS Biomater. Sci. Eng. 5, 4405-4415 (2019). Piece CAS PubMed Google Scholar
- Fused Silica CAS 60676-86-0: Identification, Properties and Safety Data
Buying Silica on Alibaba: How to Verify Suppliers and Avoid Common Risks
What is silica (SiO₂)?
silica aerogel powder Tuna, B. G. et al. Detection of viruses by probe-gated silica nanoparticles directly from swab samples. Talanta 246, 123429 (2022). Piece CAS PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
silica anti caking agent MSNs are gradually being developed as promising drug delivery carriers due to their brilliant biocompatibility, biodegradability, and greatly ordered pore structure. Owing to the great flexibility in tuning the surface properties of MSNs, specific surface functionalization modification of MSNs can achieve precise modulation of drug delivery behavior, thus to meet the application requirements. Currently, the most researched is the construction of stimuli-responsive MSNs-based drug delivery system (Fig. 6c ), i.e., when MSNs reach the lesion site, the release of drugs is controllably stimulated by specific internal or external components, thus achieving the improved drug utilization and staying away from drug leakage at non-lesion sites. 259, 272, 331 The most core step in this process is connecting some caps with stimulus-responsive properties onto the MSNs surface, which can be called gatekeepers, 119, 158 nanovalves, 332, 333 or others. Once the therapeutic drug is filled into the mesopore of MSNs, the pore entrances are blocked by the caps to prevent the drug from diffusing out. Under normal physiological conditions, the caps always keep the pores in a closed state, but when reaching to the lesion, the caps are separated under the stimulation of certain components, which in turn induces targeted on-demand release of drugs. These caps can be polymers, 334 metal/metal compound NPs, 170, 335 biomolecules, 336 etc. While exogenous stimuli such as light, ultrasound, magnetic field and electric field, endogenous stimuli such as temperature, pH, redox agents, and enzymes, can activate the caps. Several examples about the surface modification of MSNs and the corresponding stimuli-responsive plans are briefly clarified here.
What drives silica raw material prices?
fused silica powder
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.